Inceptor Bio and Avectas Announce Collaboration to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors

October 12, 2022

GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Process

September 20, 2022

Avectas Announces New Chief Technology Officer

August 2, 2022

Avectas announces publication in leading cell therapy journal Cytotherapy

May 10, 2021

AVECTAS Leads €7.23 million Consortium Awarded Part Funding From Disruptive Technologies Innovation Fund

April 22, 2021

AVECTAS Appoints Daniel Castro as Chief Business Officer

January 11, 2021

Avectas Opens Canadian Development Site

November 5, 2020

Avectas and UC Davis Collaborate on Cell Engineering Technology

June 8, 2020

Avectas and ONK Therapeutics to develop off-the shelf cancer therapy

May 6, 2020

Avectas Completes Significant Series C Funding Bringing Total Invested Equity to Over $40 Million

April 16, 2020

Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies

March 24, 2020

Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies

March 3, 2020

Avectas joins the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy

January 16, 2020

Avectas Raises $10 Million in Equity Finance

April 9, 2019

Avectas named ‘Bio Science Lab of the Year’ at The Irish Laboratory Awards 2019

March 7, 2019

Avectas shortlisted in the ‘US- Ireland Research Innovation Awards’

March 7, 2019

Maynooth team secures €2.1m EU funding for cancer therapy

March 20, 2018